Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma
Clinical trial NCT02254954 · TERMINATED
Trial details
- NCT number
- NCT02254954
- Sponsor
- Actelion
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-08
- Primary completion
- 2016-09-29
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.